Invasive Meningococcal Disease in Italy: from the analysis of national data to an evidence-based vaccination strategy.

Conclusions: In the period from 2011 to 2017, the incidence of IMDs increased in Italy. The increase, although probably due to better surveillance, highlights the high level of circulation of non-B serogroups and the importance of the disease in the adult population. Our analysis supports an anti-meningococcal vaccination plan in Italy that should include the highest number of preventable serogroups and be aimed at vaccinating the whole population through a multicohort strategy.
Source: Journal of Preventive Medicine and Hygiene - Category: International Medicine & Public Health Authors: Source Type: research